The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jun. 13, 2023

Filed:

Oct. 22, 2020
Applicant:

Incyte Corporation, Wilmington, DE (US);

Inventors:

Xiaozhao Wang, Mt. Laurel, NJ (US);

Pei Gan, Claymont, DE (US);

Taisheng Huang, Wilmington, DE (US);

Chao Qi, Newark, DE (US);

Ding-Quan Qian, Newark, DE (US);

Liangxing Wu, Wilmington, DE (US);

Wenqing Yao, Chadds Ford, PA (US);

Zhiyong Yu, Wilmington, DE (US);

Fenglei Zhang, Berwyn, PA (US);

Le Zhao, Wilmington, DE (US);

Chunhong He, Wilmington, DE (US);

Assignee:

Incyte Corporation, Wilmington, DE (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 497/04 (2006.01); C07D 487/04 (2006.01); C07D 491/056 (2006.01); C07D 519/00 (2006.01); A61P 35/00 (2006.01); A61P 25/00 (2006.01); A61P 9/00 (2006.01); A61P 29/00 (2006.01);
U.S. Cl.
CPC ...
C07D 487/04 (2013.01); A61P 9/00 (2018.01); A61P 25/00 (2018.01); A61P 29/00 (2018.01); A61P 35/00 (2018.01); C07D 491/056 (2013.01); C07D 519/00 (2013.01);
Abstract

This application relates to compounds of Formula (I): or pharmaceutically acceptable salts or stereoisomers thereof, which modulate the activity of adenosine receptors, such as subtypes A2A and A2B receptors, and are useful in the treatment of diseases related to the activity of adenosine receptors including, for example, cancer, inflammatory diseases, cardiovascular diseases, and neurodegenerative diseases.


Find Patent Forward Citations

Loading…